Charles H. Brown, MSPharm, RPh, CACP

Patients may have questions about taking antioxidants.

Patients may have questions about taking antioxidants.

Factor V Leiden thrombophilia and the comparative risks of oral anticoagulants are discussed.

The role of protein C and S deficiencies in blood clots and updates on hormonal contraceptives and acute coronary syndrome are presented.

Pharmacists can and should play a vital role in educating patients about prostate specific antigen testing and current knowledge about prostate cancer.

Patients with chronic pain are prime candidates for a medication review because of possible interactions, toxicities, and adherence issues.

Post-marketing data for rivaroxaban and new understandings about NSAIDs and cardiovascular disease are presented.

Post-marketing data for rivaroxaban and new understandings about NSAIDs and cardiovascular disease are presented.

Updates on anticoagulation therapy and oral contraceptives, intracranial hemorrhage, and pulmonary embolisms are presented.

Updates on anticoagulation therapy and oral contraceptives, intracranial hemorrhage, and pulmonary embolisms are presented.

Updates on anticoagulation therapy and oral contraceptives, intracranial hemorrhage, and pulmonary embolisms are presented.

The safety profile and efficacy of newer anticoagulants are examined along with a drug in the anticoagulation pipeline.

The wider range of symptoms found in Asperger's syndrome makes the disorder a challenge to diagnose and treat.

Attention-deficit/hyperactivity disorder is a complex developmental condition that often negatively influences a patient's academic, professional, or social life. Treatment is usually multifaceted and complicated, and requires careful monitoring.